Market Cap: $6.71B
AI
Amneal Pharmaceuticals, Inc.
AMRX
NASDAQ (NASDAQ Global Select)USD
Market Cap: $6.71B
Amneal Pharmaceuticals makes strategic moves to strengthen its position in the biosimilars market, unveiling its acquisition of Kashiv BioSciences. This pivotal acquisition will incorporate over 20 bi…
Amneal Pharmaceuticals Prepares for Upcoming Financial Results Announcement Amneal Pharmaceuticals, Inc., a global biopharmaceutical company headquartered in Bridgewater, NJ, is set to release its fou…
Amneal Pharmaceuticals Gears Up for Key Investor Conferences Amneal Pharmaceuticals, Inc., a prominent player in the pharmaceutical industry, is set to showcase its leadership at two major upcoming in…
Amneal Pharmaceuticals Prepares for Key Investor Conferences Amid Expansion Efforts Amneal Pharmaceuticals, Inc., a prominent player in the pharmaceutical industry based in Bridgewater, NJ, is gearing…
Amneal Pharmaceuticals Takes Major Steps in Migraine Treatment with DHE Autoinjector Amneal Pharmaceuticals, Inc., based in Bridgewater, New Jersey, is advancing its strategic initiatives with the res…
Amneal Pharmaceuticals Advances Pain Management Solutions with Innovative Autoinjector Amneal Pharmaceuticals, Inc., a global pharmaceutical firm based in Bridgewater, New Jersey, recently announces a…
Amneal Pharmaceuticals: Strategic Moves Fuel Growth Amid Financial Challenges Amneal Pharmaceuticals, Inc. demonstrates a robust performance in the third quarter of 2024, reporting net revenues of $70…